| Michael
Dunn |
 Mike Dunn was appointed Science Foundation Ireland Professor of Biomedical Proteomics at the Conway Institute of Biomolecular and Biomedical Research, University College Dublin in November 2004.
Professor Dunn’s research team is based in the Proteome Research Centre and is carrying out a comprehensive programme of proteomics research in the areas of cardiovascular disease, transplantation and neurological disease. The emphasis of the research is on understanding molecular processes involved in human disease and on the identification of novel biomarkers of disease that have the potential for development as diagnostic/prognostic markers or as therapeutic targets. In collaboration with Professor Stephen Pennington (Director of the Proteome Research Centre), Professor Dunn is also interacting closely with other research groups, both within UCD and elsewhere, who are applying proteomics in their research programmes. Prior to his move to UCD, he was Professor of Proteomics at the Institute of Psychiatry, King’s College London (2001-2004), where he developed his interest in neuroproteomics. From 1988-2001 he was a senior staff member in the National Heart and Lung Institute Division of Imperial College of Science, Technology and Medicine, London, UK, where his research focused on laboratory and clinical studies of heart disease and transplantation. Professor Dunn is the current President of the British Society for Proteome Research (BSPR) and the Editor-in-Chief of the journal, Proteomics, launched in 2001 and published by Wiley-VCH. He is a founder Council Member of the Human Proteome Organisation (HUPO), is a member of the Executive Committee of the HUPO Brain Proteome Project, and a member of the Executive Committee of the European Proteomics Association.
|
|
